Effect of standard low-dose anthracycline chemotherapy on late congestive heart failure in breast cancer survivors aged between 50 and 59 at diagnosis: A nationwide study

OBJECTIVES: Although chemotherapy-induced congestive heart failure (CHF) is a well-known adverse event in cancer survivors, the long-term risk of standard low-dose anthracycline has not yet been reported. This study aimed to investigate the long-term effects of standard anthracycline on late CHF in...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Il Yong, Lee, Jong Won, Moon, Hyeong-Gon, Shin, Kyung Hwan, Han, Wonshik, Son, Byung Ho, Ahn, Sei-Hyun, Noh, Dong-Young
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414012/
https://www.ncbi.nlm.nih.gov/pubmed/32771950
http://dx.doi.org/10.1016/j.breast.2020.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414012/
https://www.ncbi.nlm.nih.gov/pubmed/32771950
http://dx.doi.org/10.1016/j.breast.2020.07.006

Ejemplares similares